Podcasts about Rheumatology

Cheryl and Chrissy also do a deep dive into the Rheum to THRIVE program and discuss their excitement over Chrissy taking on a new role as the lead facilitator of an upcoming cohort.  Chrissy's facilitation style is flexible and responsive, letting the group's needs guide the conversation while keeping it grounded in the weekly theme. If you want a supportive, stigma-free space that helps you feel less alone, more informed, and more capable of building a full life with arthritis, Chrissy's Rheum to THRIVE group might be just right for you - learn more here.  Episode at a glance: 00:00 Welcome Back, Chrissy! Quick Catch-Up & Arthritis Background 11:23 Big Announcement: Training New Rheum to Thrive Facilitators 12:13 Why Chrissy Wanted to Facilitate (and What Participants Gain) 18:40 What a Typical Rheum to Thrive Meeting Looks Like (THRIVE Breakdown) 35:26 Rheum to Thrive Explained: Cohort Learning + Alumni Support (and Why Topics Help) 39:41 On the Fence About Support Groups? Privacy, Intimidation & Finding the Right Fit 42:30 Myths, Doom Spirals & Misinformation: What Good Facilitation Looks Like 45:45 Participation Your Way: Cameras Off, Chat-Only, Discord, and Asking for Help 51:34 Words of Wisdom: “Life Is Different, But It's Not Over” + Acceptance & Adapting Goals Medical disclaimer:  All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Book a Complimentary 15-Minute Discovery Call with Dr. Mary - https://www.drmarysanders.com/meditationsIf you're living with chronic joint pain, morning stiffness, inflammation, fatigue, or a body that feels unpredictable, you're not alone. For millions of people with rheumatologic conditions, daily life can feel like a constant negotiation with symptoms, managed, medicated, yet never fully resolved.In this episode of Energy Medicine, we explore a different question:What if your symptoms are not something to silence, but signals asking to be understood?Host Dr. Mary, a medical intuitive and chiropractor, is joined by Dr. Nisha Manek, a rheumatologist turned bestselling author, speaker, and health coach. Trained in academic medicine, Dr. Manek courageously stepped beyond a drug-only model of care after witnessing its limitations. Together, they unpack what becomes possible when science and spirit meet, and when the body's innate intelligence is finally given space to lead the healing process.This conversation offers hope, clarity, and a grounded reimagining of healing for those seeking relief beyond symptom suppression.In this episode, you'll hear:Dr. Manek's personal journey from academic rheumatology to integrative, drug-free healingWhat first caused her to question whether pharmaceuticals were the primary path to wellnessWhat recognizing the power within really means from a physiological and clinical perspectiveHow nervous system regulation, energy, and the biofield fit into modern medical understandingWhy do symptoms often appear when the body has lost regulation and coherenceWhat a new medical paradigm could look like, and what medicine is being asked to releaseWhat is at stake for patients if healing continues to focus only on symptom managementWhy this conversation mattersRheumatologic conditions are often treated as lifelong problems to manage rather than systems to understand. This episode invites a more compassionate, integrative perspective that honors the body's wisdom, supports regulation and resilience, and opens the door to healing beyond medication alone.Contact Dr. Mary:FB   / dr.maryesanders  IG   / dr.maryesanders  YouTube    / @dr.maryesanders  LinkedIn   / drmaryesanders  Website https://www.drmarysanders.com/Contact Dr. Nisha Manek:LinkedIn:   / feed  Website: https://www.nishamanekmd.com/About the podcast:Energy Medicine is hosted by Dr. Mary, a medical intuitive and chiropractor. The promise of this podcast is to provide practical energy medicine tools you can apply to everyday life, tools that support nervous system regulation, resilience, and healing beyond symptom management.

Text Dr. Lenz any feedback or questions The Hidden Fibromyalgia Epidemic: How Bias Leaves Millions Undiagnosed—and How AI Can HelpThe script explains fibromyalgia as a chronic, long-term condition marked by widespread pain, profound fatigue, cognitive difficulties (“fibro fog”), and related mood issues, affecting an estimated 2–4% of the U.S. population (7–14 million) but potentially far more due to underdiagnosis. It describes how the condition is often missed because it is “invisible,” lacks definitive objective tests, and commonly leaves patients in diagnostic limbo for about five years while being dismissed as stressed, depressed, or imagining symptoms. Although the 2016 American College of Rheumatology criteria rely on the Widespread Pain Index and Symptom Severity Score, the script argues diagnosis often fails at the moment clinicians don't suspect fibromyalgia—driven by longstanding gender and age stereotypes that frame it as a middle-aged women's disease. It highlights research showing that unbiased application of criteria yields a much closer gender split (about 59% female, 41% male), and that many more men report symptoms than receive diagnoses. The script centers on a study of over 21,000 pain-clinic patients who completed tablet questionnaires with a digital body map; an AI clustered pain patterns into nine groups and identified a “widespread heavy” cluster strongly associated with fibromyalgia, where patients were nearly 30 times more likely to have a fibromyalgia diagnosis than those with low back pain. Yet more than two thirds of patients flagged by the AI lacked a clinical fibromyalgia diagnosis; an objective “informatics proxy” applying the formal criteria found 66.3% of the widespread-heavy cluster met diagnostic criteria, while only 22.4% were diagnosed. The missed patients were more likely to be male and older, demonstrating diagnostic bias. Extrapolating from these findings, the script suggests the true U.S. population meeting criteria could be 21–42 million. It proposes integrating digital body maps and machine-learning alerts into clinic workflows to prompt unbiased evaluation, while emphasizing existing tools already work if applied. The script also frames fibromyalgia as nociplastic pain (central nervous system hypersensitivity), w Support the showWhen I started this podcast and YouTube Channel—and the book that came before it—I had my patients in mind. Office visits are short, but understanding complex, often misunderstood conditions like fibromyalgia takes time. That's why I created this space: to offer education, validation, and hope. If you've been told fibromyalgia “isn't real” or that it's “all in your head,” know this—I see you. I believe you. This podcast aims to affirm your experience and explain the science behind it. Whether you live with fibromyalgia, care for someone who does, or are a healthcare professional looking to better support patients, you'll find trusted, evidence-based insights here, drawn from my 29+ years as an MD. Please remember to talk with your doctor about your symptoms and care. This content doesn't replace per...

They also discuss safe, realistic strategies that support joint health, including tailored exercise and strength training, plus the emerging evidence on GLP-1 medications (like semaglutide/Ozempic/Wegovy) for people with obesity and arthritis. The key message: obesity is a treatable chronic condition, and care should be compassionate, individualized, and evidence-based.*Content note/ trigger warning: This episode includes discussion of body weight, obesity, BMI, and weight-loss medications (including GLP-1 drugs).  We approach this topic from a stigma-free, evidence-based perspective, as well as lived experience, but we know conversations about weight can be sensitive or activating, especially for those with a history of weight stigma, eating disorders, or body image challenges. Listener discretion encouraged.Episode at a glance:Weight and arthritis: inflammation + joint load (OA and inflammatory arthritis)Why adipose tissue can worsen pain and disease activityBMI limits: muscle loss, fat distribution, and rheumatoid cachexiaExercise myth-busting: movement helps when it's tailored and gradualStrength training for knee support and better joint mechanicsGLP-1 medications (semaglutide, tirzepatide): what research shows so farStigma-free framing: obesity is chronic, not a personal failurePractical next steps and trusted resources (Arthritis Research Canada webinar)Medical disclaimer: All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Have you longed to integrate your Christian faith into your patient care—on the mission field abroad, in your work in the US, and during your training? Are you not sure how to do this in a caring, ethical, sensitive, and relevant manner? This “working” session will explore the ethical basis for spiritual care and provide you with professional, timely, and proven practical methods to care for the whole person in the clinical setting. https://www.dropbox.com/scl/fi/qpah9kh1lttg6cm1jjop9/Bob-Mason-Ethics-of-Spiritual-Care-revised.pptx?rlkey=0emve2ja8282nv8xc4uinq1hg&st=9033htwx&dl=0

Rheumatoid Arthritis explained, including pathophysiology and typical signs and symptoms (extra articular too!). We also look at rheumatoid arthritis diagnosis (with rheumatoid factor / Anti CCP) and medications such as DMARDsPDFs available here: https://rhesusmedicine.com/pages/rheumatologyConsider subscribing on YouTube (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Rheumatoid Arthritis?0:23 Rheumatoid Arthritis Pathophysiology 2:58 Rheumatoid Arthritis Symptoms5:16 Rheumatoid Arthritis Diagnosis 7:02 Rheumatoid Arthritis Treatment LINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesMSD Manual Professional Edition (2025) Rheumatoid arthritis. MSD Manual Professional Edition. Available at: https://www.msdmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/joint-disorders/rheumatoid-arthritisBMJ Best Practice (2025) Rheumatoid arthritis – Symptoms, diagnosis and treatment. BMJ Best Practice. Available at: https://bestpractice.bmj.com/topics/en-gb/105Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. Kelly and Firestein's Textbook of Rheumatology. 11th ed. Elsevier; 2021.McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219.Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–2038.Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 10th ed. Elsevier; 2021.Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Elsevier; 2020.Please remember this podcast and all content from Rhesus Medicine is meant for educational purposes only and should not be used as a guide to diagnose or to treat. Please consult a healthcare professional for medical advice. 

Dr. Birnbaum also addresses common early fears, including confusion about autoimmune disease and anxiety around immunosuppressive medications, reframing treatment as dialing down an overactive immune response rather than taking away your immune system. Throughout the episode, he encourages self-advocacy, realistic hope, and partnership with your care team, and shares insights from his book“Living well with autoimmune diseases”  A Rheumatologist's Guide to Taking Charge of Your Health. The takeaway is empowering and hopeful: we're living in a “golden era” of RA care, with more effective treatments and real reason to believe a full, meaningful life is possible alongside this diagnosis.Episode at a glance:00:20 Dr. Burnbaum's Background and Passion for Arthritis & Neurology05:19 The Diagnostic Process in Rheumatology08:59 Understanding Inflammatory Arthritis15:22 Explaining Autoimmune Diseases and Inflammation23:11 The Role of Immunosuppressive Therapies28:16 Personalized Treatment Plans in Rheumatology30:50 Understanding Diagnostic Criteria and Nuances31:31 Dealing with Diagnostic Ambiguity32:57 Empowerment Through Patient-Doctor Partnership38:10 Practical Tips for Patient Empowerment46:03 Realistic Hope and Coping Strategies56:34 Concluding Thoughts and ResourcesMedical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Those who hope to honor God and advance Jesus' Kingdom face powerful opposition from spiritual, physical, and psychological enemies. Successful launching and long term fruitfulness depends on recognizing and, in dependence on the Holy Spirit, waging war against those enemies.

In this episode, we explore Antiphospholipid Syndrome (APS) with Dr. Yu (Ray) Zuo, beginning with a clear, clinically grounded explanation before diving into the personal and scientific journey that drew him to this notoriously complex disease. Along the way, Dr. Zuo shares a case that forever changed how he understands APS, then takes us inside his latest Arthritis & Rheumatology study, where machine learning reveals hidden patterns that may reshape how we think about patients and risk. The conversation moves from bedside to bench and back again, tackling what AI can—and can't—do for rheumatology, where APS research is headed next, and what early investigators need to know to build impactful careers. 

Season FIVE Episode SEVEN of the Your Story Our Fight® podcast welcomes Dr. Sheetal Desai, MD, MSED. Sheetal Desai completed medical school at the University of Southern California (USC) followed by Internal Medicine residency and Rheumatology fellowship at UCLA.  She pursued a Master of Science in Medical Education from the USC Rossier School of Education.  She joined the University of California, Irvine (UCI) as rheumatology faculty in 2007.  She was program director of the UCI Rheumatology Fellowship for 10 years, Chief of Rheumatology for 7 years and is currently Executive Vice Chair of Medicine.  Her clinical interests are Systemic Lupus Erythematosus, collaboration across specialties to create Multidisciplinary clinics, and gender equity in medicine.

Medical missionaries often feel powerful emotional burden from moral injury, and it is a leading cause of departure from the mission field. But we have learned proven methods of preventing and dealing with moral injury. Use God’s powerful methods to protect yourself and your team, and to grow in wisdom and spirit!

The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist. The Usual Suspects: Established and Emerging Predictor Variables for Remission in Rheumatoid Arthritis - doi.org/10.3899/jrheum.2025-0476 Do Monosodium Urate Crystals Reduce at Different Rates in Joints and Tendons During Urate-Lowering Therapy? A Dual-Energy Computed Tomography Study - doi.org/10.3899/jrheum.2025-0122 Incidence and Predictors of Secondary Failure to Biologic Therapy in Patients With Psoriatic Arthritis - doi.org/10.3899/jrheum.2025-0518 Comorbidity Development and Mortality During 10 Years of Follow-up in a Danish Nationwide Cohort of 3178 Patients With Systemic Lupus Erythematosus - doi.org/10.3899/jrheum.2025-0015 Investigating Factors Associated With Respiratory Syncytial Virus Vaccination and Breakthrough Infection Among Patients With Systemic Autoimmune Rheumatic Diseases - doi.org/10.3899/jrheum.2025-0934

Dr Jenny Lemon speaks with Giulia Varnier, a paediatric rheumatology consultant and Loveday Jago, a paediatric gastroenterology consultant, to talk about the joined up working between the specialties. They share tips from running a combined clinic and case examples where shared decision making has been crucial to patient care.Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK.BSR is the UK's leading specialist medical society for rheumatology and MSK health professionals. To discover how we can support you in delivering the best care for your patients, visit our website.

To celebrate 101 episodes, I sit with Leonard H. Calabrese, DO, to discuss his unique career in Rheumatology, spanning immunology, HIV, MECFS, IRES, CNS vasculitis and more. We also discuss how medical history shaped our careers.  ·        Intro 0:12 ·        Welcome Leonard H. Calabrese, DO 3:11 ·        A quick friendship begins over medical history 4:14 ·        How Healio Rheuminations began and where the show is now 5:38 ·        How Dr. Calabrese got interested in medical history 7:11 ·        Serotherapy 10:52 ·        Why patients get certain diseases 12:33 ·        Dr. Calabrese's career trajectory 14:43 ·        One day in 1981… 17:52 ·        A few things happened in the 90's 20:20 ·        Tell us about CNS vasculitis 21:53 ·        Don't be afraid to reinvent yourself 24:30 ·        Checkpoint inhibitors 25:09 ·        How do you keep up? 26:43 ·        Placebo science 28:25 ·        Do you think we'll ever be able to answer where diseases come from? 29:33 ·        Thank you, Dr. Calabrese 31:01 ·        Thanks for listening 31:26 We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

Dr. Gillis updates us all with fibromyalgia as no longer belonging in Rheumatology but Immunology. His research developed a blood test to detect defective white blood cells as the source and causation of the illness. The blood test website is www.fm1test.com & the compound that results in eliminating symptoms is www.imbxx.com a 30 day supply to provide a working solution for those who suffer from the illness.

Support the Institute today. https://givenow.nova.edu/the-institute-for-neuro-immune-medicine-inim-2025   In this episode, we compile selected highlights from the most impactful podcasts of 2025, featuring insights and clinical perspectives from leading experts, including Dr. Richard C. Deth, Dr. Marc Kesselman, Dr. Nancy Klimas, Dr. Payam Hakimi, and Dr. Philip DeFina. Together, they address critical topics such as ME/CFS, Long COVID, and neuroinflammation. This episode also highlights key themes frequently explored throughout the year, including optimizing metabolic health, the essential role of nutrient-dependent healing, and the impact of environmental toxins and mycotoxins on the body. The experts further share insights into homeopathy, post-traumatic symptoms following neuroinflammation, and the biological and lifestyle factors that help protect brain health. Ultimately, this compilation underscores the importance of communication, trust, and patient-centered relationships in delivering effective care and supporting meaningful healing outcomes. Dr. Richard Deth is a molecular neuroscientist at Nova Southeastern University, where he has worked since 2014 after 38 years at Northeastern University. His research focuses on brain disorders like autism, exploring neurodevelopment, aging, attention, and learning. He studies neurons' metabolic features, particularly the antioxidant glutathione (GSH), its role in methylation, and epigenetic regulation. Dr. Deth investigates how casein and gluten-derived opioid peptides impair cysteine absorption, affecting antioxidant levels and epigenetics. His current work examines oxidative stress, inflammation, and the anti-inflammatory potential of cobinamide, a vitamin B12 precursor. LinkedIn: https://www.linkedin.com/in/richard-deth-2383175/    Dr. Marc Kesselman is the chair and associate professor at the Department of Internal Medicine at Dr. Kiran C. Patel College of Osteopathic Medicine. He is also the chief of the Division of Rheumatology at Nova Southeastern University. Dr. Kesselman received his medical degree from Des Moines University College of Osteopathic Medicine and has been in practice for more than 20 years.  LinkedIn: https://www.linkedin.com/in/marc-m-kesselman-d-o-facoi-facc-facr-6491479/    Dr. Nancy Klimas, a clinical immunologist by training, is the director of the Institute for Neuro-Immune Medicine who has allotted her life to helping other people find cures for their complex illnesses that were once considered helpless. She works with her fellow medical experts in researching and analyzing the deeper causes of such diseases, particularly on the neuro-immunity side, to provide the best option suited for every single case or story they handle.   LinkedIn: https://www.linkedin.com/in/nancy-klimas-49255178/ Instagram: https://instagram.com/nancyklimas     Twitter: https://x.com/ngklimas?s=20      Dr. Payam Hakimi is the Medical Director of Body of Harmony in Beverly Hills, CA, and Miami, FL, offering a range of services including Functional Medicine, Anti-aging Medicine, Hormone Replacement Therapy, Clinical Homeopathy, and IV Nutrition Therapy. A board-certified Doctor of Osteopathic Medicine, Dr. Hakimi blends conventional and complementary medicine with a personalized approach to care. He earned his DO from Western University of Health Sciences, completed his residency at LAC+USC, and served as Chief Resident and Assistant Clinical Professor at USC Keck School of Medicine. A national leader in homeopathic education, Dr. Hakimi is a senior faculty member at the CEDH and the only U.S. physician to consistently lecture on homeopathy at medical conferences, sharing his expertise with diverse healthcare audiences. Instagram: https://www.instagram.com/bodyofharmony/ YouTube: https://www.youtube.com/c/bodyofharmony Instagram: https://www.instagram.com/boironusa/ LinkedIn: https://www.linkedin.com/in/drpayamhakimi/ X: https://x.com/Bodyofharmony   Learn more about the Body of Harmony through their website: https://bodyofharmony.com/   Dr. Philip DeFina has over 40 years of experience as a neuropsychologist and cognitive neuroscientist. He is most known for developing novel, groundbreaking treatment protocols for traumatic brain injury, coma, autism spectrum, and PTSD. He is the founder and Chief Scientific Officer of the International Brain Research Foundation (IBRF). Dr. DeFina previously served on the NYU faculty as an associate professor of neurology and psychiatry at the New York University School of Medicine and the Bellevue Hospital Center. He was a forensic neuropsychologist at the Mount Sinai-Elmhurst Hospital Medical Center and was an adjunct professor at the University of Maryland Psychology Department. Dr. DeFina was also the founder and first director of the Fielding Graduate University's Post-Doctoral Clinical Neuropsychology Training Program. Dr. DeFina subsequently co-founded the school neuropsychology training program at Texas Women's University and co-founded the American Board of School Neuropsychology, and was one of the original founding members of the American Board of Pediatric Neuropsychology.   Website: https://ibrfoundation.org/ Facebook: https://www.facebook.com/people/International-Brain-Research-Foundation/100070365733222/ Instagram: https://www.instagram.com/save.a.soldier/ YouTube: https://www.youtube.com/@IBRFinc   Learn more about the International Institute for Brain Enhancement. Website: https://usbrainenhancement.com/ Instagram: https://www.instagram.com/braininstitute.fl/   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy  YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy     Sign up today for our newsletter. https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d    This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here.   Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ Twitter: https://www.twitter.com/NSU_INIM

In this episode, we sit down with Dr. William Harvey, the newly appointed President of the American College of Rheumatology and a dedicated volunteer of nearly 20 years. Dr. Harvey shares what it's like stepping into the presidency, the key priorities shaping the year ahead, and how the ACR is approaching strategy, advocacy, partnerships, and leadership during this pivotal moment for the field. 

Today's topic is one I've wanted to discuss for a very long time and one that's particularly troubling to me: calcinosis. I was absolutely thrilled when Dr. Ariane Herrick agreed to join me for this conversation. She is incredibly knowledgeable on the subject and shared such valuable insight and information about this challenging condition. I'm so grateful for her time and expertise

In this episode of the Lupus Foundation of America's The Expert Series podcast, Dr. Cindy Aranow discusses the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus (SLE). She explains the importance of these guidelines in providing evidence-based recommendations for individualized patient care, the process of developing and updating the guidelines and key changes that emphasize optimal disease control and reducing long-term steroid use. Dr. Aranow highlights the need for patient engagement and communication with health care providers to ensure effective management of lupus.This episode of The Expert Series was sponsored by AstraZeneca. The Lupus Foundation of America would like to thank AstraZeneca for their support of education programs for people with lupus.Sign up to receive emails from the Lupus Foundation of America (LFA) when new episodes are published: https://support.lupus.org/site/SPageNavigator/email_subscribe_expert_series.htmlEpisode Takeaways:Treatment guidelines are recommendations, not mandates, and support - not replace - your doctor's clinical judgment.Lupus is a highly individualized disease, so care must be tailored to each person.A diverse group of experts develops and regularly updates guidelines based on new research.Guidelines help clinicians navigate complex and evolving medical evidence.Recent guidelines emphasize achieving remission or low disease activity while reducing long-term steroid use.Open communication and active patient involvement are essential for effective treatment decisions. Related Resources:Ask a Lupus Health Educator (LFA): https://www.lupus.org/care-support/ask-a-health-educatorFind Support Near You (LFA): https://www.lupus.org/resources/find-support-near-youNational Resource Center on Lupus (LFA): https://www.lupus.org/resourcesThe Expert Series (LFA): https://www.lupus.org/resources/lupus-the-expert-seriesNew Lupus Treatment Guidelines (ACR): https://rheumatology.org/press-releases/new-lupus-sle-clinical-practice-guidelines-released

Flu season hits differently when you're living with autoimmune disease or taking rheumatology medications. In this video, I break down what to do if you think you have the flu, which symptoms should prompt urgent care, and how to think about common rheumatology meds when you're sick.We cover:Flu vs. “just a cold”: key symptoms to watchWhen to call your rheumatology teamFever, dehydration, and red flags that need urgent evaluationHow to approach steroids, DMARDs, biologics, and JAK inhibitors when you're ill (general guidance)Flu prevention: vaccines, household exposure, and practical next stepsThis video is for education only and isn't personal medical advice. If you're immunocompromised, pregnant, or your symptoms are severe, please seek urgent medical care.#flu #influenza #rheumatollgic #autoimmune #inflammation #fluandrheumatologicmedications #dmards #biologics #fluprevention #vaccinations 

Dr. Jack Cush reviews rheumatology's highlights, advances and noteworthy trends from the past year - 2025!

On this episode of Critical Care Time, we tackle the enigma - shrouded in mystery and caped in uncertainty - know as rheumatologic emergencies in the critically ill patient! We sit down with Dr. Marcela Ferrada - a QUADRUPLE boarded intensivist/rheumatologist/ID specialist and internist - who guides us through her approach to rheumatologic emergencies in the sickest of the sick. As we often do, we approach this via a pragmatic, cased-based journey for your listening pleasure. Please check it out, learn all you can, and as always - let us know your thoughts and leave a review!Special thanks to returning sponsor, Seastar Medical for supporting us with this production! Hosted on Acast. See acast.com/privacy for more information.

Joint pain is a common concern in pediatric practice. If a child is limping after sports or describes vague aches and pains, it often points to a minor injury or a self-limited condition. But in some cases, joint pain may signal something more serious. The challenge for pediatricians is knowing how to distinguish benign, mechanical causes from symptoms that warrant further evaluation. In this episode, we explain how to identify red herrings versus true red flags in pediatric joint pain. While awaiting a rheumatology referral, we'll talk about what primary care pediatricians can do in the meantime to support children and families facing the possibility of arthritis.    This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics National Conference in Denver, Colorado. Angela Chun, MD, is the associate program director for the Division of Rheumatology at Lurie Children's Hospital of Chicago. She is also an assistant professor at the Northwestern University Feinberg School of Medicine.  Some highlights from this episode include: The most common reasons for joint pain in children Understanding juvenile idiopathic arthritis (JIA) and how it presents Common pitfalls that may lead to misdiagnosis What providers can do in their offices before a referral  For more information on Children's Colorado, visit: childrenscolorado.org. 

Are you skipping your arthritis medications out of fear? You're not alone—but the hidden costs can be bigger than you realize. In this Rheumatology 101 episode, Dr. Isabelle Amigues breaks down why untreated inflammatory arthritis can lead to more pain, joint damage, and long-term health risks. Learn the real risks of stopping your meds, how to talk to your doctor about concerns, and what science says about the safest path to remission.  Don't let fear stand between you and your healthiest future—watch now to get empowered, informed, and supported!#Rheumatology101 #ArthritisAwareness #MedicationMyths #JointHealth #RheumatologistExplains #AutoimmuneSupport #patientempowerment 

Send us a textDr. R. Michelle Koolaee is a board-certified rheumatologist with over 12 years of experience in academic and multi-specialty practices across Los Angeles. In 2025, she opened a direct care rheumatology practice in Pasadena to move beyond the constraints of 15-minute visits and provide patients with more time, access, and personalized care. She now shares her journey to help other physicians explore and implement the direct care model. Connect with her: Email: michelle@drrmichellekoolaee.com Website: https://www.drrmichellekoolaee.comFree Newsletter: https://mailchi.mp/drrmichellekoolaee/subscribe Support the show*NEW!* Are you ready for Direct Care? Start with this Google Form Readiness Scorecard here --> Contact me here --> MASTERING PRIVATE PRACTICE CONFERENCE by Doctors On Social Media. Recording: Use my affiliate link to attend, here --> Record your question easily here --> FREE Direct Care Guide to get you started --> Join the Direct Care Society private Facebook group here. Monthly coaching sessions & a community that gets you. --> Own a DSC practice and want to share your story? Apply here EMR I'm currently using in my Direct Care practice Simple Practice HIPAA Compliant Email with Paubox Get $250 Credit Here Find me on LinkedIn https://linkedin.com/in/teadpm More resources teadpm.com

Send us a textDr. R. Michelle Koolaee is a board-certified rheumatologist with over 12 years of experience in academic and multi-specialty practices across Los Angeles. In 2025, she opened a direct care rheumatology practice in Pasadena to move beyond the constraints of 15-minute visits and provide patients with more time, access, and personalized care. She now shares her journey to help other physicians explore and implement the direct care model. Connect with her: Email: michelle@drrmichellekoolaee.com Website: https://www.drrmichellekoolaee.comFree Newsletter: https://mailchi.mp/drrmichellekoolaee/subscribe Support the show*NEW!* Are you ready for Direct Care? Start with this Google Form Readiness Scorecard here --> Contact me here --> MASTERING PRIVATE PRACTICE CONFERENCE by Doctors On Social Media. Recording: Use my affiliate link to attend, here --> Record your question easily here --> FREE Direct Care Guide to get you started --> Join the Direct Care Society private Facebook group here. Monthly coaching sessions & a community that gets you. --> Own a DSC practice and want to share your story? Apply here EMR I'm currently using in my Direct Care practice Simple Practice HIPAA Compliant Email with Paubox Get $250 Credit Here Find me on LinkedIn https://linkedin.com/in/teadpm More resources teadpm.com

In this episode of HSS Presents, rheumatologist Dr. Caroline Siegel is joined by HSS colleagues Dr. Lisa Samaritano and Dr. Jane Salmon to discuss managing pregnancy for patients with autoimmune rheumatic diseases. They emphasize that most patients have successful pregnancies, but conditions like systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) carry greater risks, including preeclampsia and placental insufficiency. Successful outcomes rely on preconception planning, which includes achieving quiescent disease for about six months on pregnancy-compatible medications and screening for antibodies. Dr. Salmon also shares exciting clinical trial results using a TNF inhibitor to improve pregnancy outcomes in high-risk APS patients.

What is a call? How does a person know if God is calling them to mission service? Join in a discussion as these and other questions are addressed.

This episode explores the multifaceted nature of innovation in orthopedic surgery, from creative problem-solving in clinical practice to collaborating with industry on new device development. Dr. Robert Orfaly hosts a conversation with Dr. Amy Ladd, Chief of Stanford's Chase Hand & Upper Limb Center, a recognized leader in the field whose career includes pioneering research in thumb CMC arthritis, patents, and instrument design. Dr. Amy Ladd shares her perspective on fostering intellectual curiosity early in one's career, the process of turning a simple idea into intellectual property, and the evolving relationship between academic institutions, industry, and orthopedic surgeons. Practical advice is given for trainees, mid-career surgeons, and anyone inspired to pursue innovation, with stories ranging from creating specialized surgical instruments to applying motion analysis technology from upper limb research to optimizing golf swings. The episode also discusses the importance of networking across disciplines and the realities of developing and commercializing new medical devices, emphasizing that creativity and collaboration are central to advancing patient care. Host: Robert Orfaly, MD, MBA, FAAOS, Editor in Chief, AAOS Now  Guest: Amy Ladd, MD, FAAOS, Chief of Stanford's Chase Hand & Upper Limb Center; Chief of the Children's Hand Clinic at Lucile Salter Packard Children's Hospital at Stanfordand; and the Elsbach-Richards Professor of Surgery and Professor, by courtesy, of Medicine (Immunology & Rheumatology) and Surgery (Plastic and Reconstructive Surgery), at Stanford University Medical Center Production and Editing: MK Quinn Media

In this collaborative episode between the RCP Medicine Podcast and the British Society for Rheumatology's Talking Rheumatology series, consultant rheumatologist Dr Tam Malley from the Royal Free Hospital joins Dr Vasiliki Thanopoulou, RCP Clinical Education Fellow and registrar, to explore the complexities of inflammatory myositis. Through a compelling case study and rich clinical discussion, they unpack the diagnostic challenges, multidisciplinary considerations, and treatment strategies for this rare autoimmune condition.Listeners will gain insights into recognising subtle signs, interpreting investigations, and understanding the importance of early intervention. Whether you're a rheumatologist, general physician, or trainee, this episode offers practical pearls and thoughtful reflections on managing inflammatory myositis in real-world settings.ResourcesIdiopathic inflammatory myopathies - Symptoms, diagnosis and treatment | BMJ Best PracticeBritish Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy | Rheumatology | Oxford AcademicInternational Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative | Nature Reviews RheumatologyPolymyositis Masquerading as Motor Neuron Disease | Neurology | JAMA Neurology | JAMA NetworkRCP Links Education Events Membership Improving care Policy and campaigns RCP Social Media Instagram LinkedIn Facebook X Bluesky Music: Episode 50 onward - Bensound.com Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas

Low resource settings require much innovation and streamlining resources to meet set goals. With healthcare becoming more commercial and profit driven, missional healthcare in low resource settings faces many challenges. Sustainability is a big question with people finance , and equipment scarce and hard to come by. Missional models of healthcare often run into hurdles of sustainability, longevity and relevance even as healthcare slowly turns into business. In this setting of multifactorial challenges and increasing compliances how can missional healthcare be relevant and sustainable? Many saints of God have committed their lives to fulfil this great commission in some of the most underserved and unreached areas of the world. With the birth of Emmanuel Hospital Association (EHA) a different model of missional healthcare emerged in India. Over the last 55 years of its existence, EHA has shown that through all the challenges, this may be one of the ways to sustain missional healthcare in areas of need. With increasing divide between the rich and poor, overwhelmed government systems, a ruthless insurance system, and high end corporate healthcare, it is still possible for missional healthcare to provide low cost, high quality, technologically advanced care to people in need while remaining sustainable. We bring lessons from India and our experience with Emmanuel Hospital Association over the last 3 decades.

Please visit answersincme.com/860/99534447-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in dermatology and rheumatology discuss the use of TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA. Upon completion of this activity, participants should be better able to: Discuss the rationale for using novel TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA; Review the latest evidence on the use of novel TYK2 inhibitors in patients with psoriatic disease, including PsA; and Outline multidisciplinary strategies for the optimal integration of novel TYK2 inhibitors into treatment plans for patients with psoriatic disease, including PsA.

Please visit answersincme.com/860/99534447-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in dermatology and rheumatology discuss the use of TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA. Upon completion of this activity, participants should be better able to: Discuss the rationale for using novel TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA; Review the latest evidence on the use of novel TYK2 inhibitors in patients with psoriatic disease, including PsA; and Outline multidisciplinary strategies for the optimal integration of novel TYK2 inhibitors into treatment plans for patients with psoriatic disease, including PsA.

In this RCP Medicine podcast and BSR Talking Rheumatology podcast collaboration Dr Roz Benson and Dr Lisa Waters discuss a challenging case of a patient with an acute hot joint who presented to the acute medical unit. It covers wide ranging topics including diagnosis and management of gout, investigation of the acute hot joint and how to treat septic arthritis. Dr Roz Benson is a Consultant Rheumatologist at NHS University Hospitals of Liverpool Group, BSR Digital Learning Editor, and Talking Rheumatology host and Dr Lisa Waters is a Rheumatology and Acute Medicine Consultant at Manchester University Hospitals. She is clinical lead for Acute Medicine and a former RCP Chief Registrar.Resources NICE: Diagnosis and management of gouthttps://www.nice.org.uk/guidance/ng219/chapter/RecommendationsThe British Society for Rheumatology Guideline for the Management of Gout https://academic.oup.com/rheumatology/article-abstract/56/7/e1/3855179?redirectedFrom=fulltextIf you liked this check out related Talking Rheumatology spotlight episodes Episode 9 - Diagnosis and management of goutBonus episode - a tricky case of infection and arthritisRCP Links Education Events Membership Improving care Policy and campaigns RCP Social Media Instagram LinkedIn Facebook X Bluesky Music: Episode 50 onward - Bensound.com Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas

Replay of RheumNow Live 2025 - Vasculitis Featuring:  - Dr. Michael Wechsler: Management of EGPA in 2025 - Dr. Rennie Rhee: Imaging in Vasculitis - Dr. Richard Conway: Modern Treatment of PMR

They also reflect on new insights into mental health, cognitive dysfunction, and  the importance of the microbiome as part of lifestyle interventions. This episode offers hope, practical advice, and the latest research to help manage your condition more effectively.Episode at a glance:00:00 Introduction to Rheumer Has It00:30 Importance of the ACR Annual Conference03:02 Sessions on Patient Health Literacy and Support Groups07:10 Dietary Interventions and Microbiome Research10:54 Mental Health and Fatigue in Rheumatic Diseases15:50 Innovative Treatments: CAR T-Cell Therapy and Vagus Nerve Stimulation19:50 GLP-1 Medications and Their Benefits25:23 Cognitive Dysfunction in Rheumatic Diseases29:22 Spotlight on Sjogren's Disease31:50 Conclusion and Key TakeawaysMedical disclaimer: All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Replay of RheumNow Live 2025 - Spondyloarthritis Sponsored by AbbVie Featuring:  Dr. Desiree van der Heidje - Advances in Treatment of Spondyloarthritis   Dr. Jennifer Cather - Progress in Hidradenitis Supprativa Dr. Catherine Bakewell - Imaging Evaluation of Spondyloarthritis

In this week's nugget we revisit our interview with Carlijn Wagenaar from the Plants for Joints study, as they launch their 'Plants for Health' programme to help those suffering from a range of chronic conditions  - not just joint problems.Order the e-or printed book and sign up for the programme:https://plants-for-health.com/ References for the programme:Two-Year Follow-Up of a Multidisciplinary Lifestyle Intervention for Rheumatoid Arthritis and OsteoarthritisCarlijn A. Wagenaar, Wendy Walrabenstein, Marike van der Leeden et al.Arthritis Care Res (Hoboken), 2025Effect of a multidisciplinary lifestyle intervention on body composition in people with osteoarthritis: Secondary analysis of the “Plants for Joints” randomized controlled trialCarlijn A. Wagenaar, Wendy Walrabenstein, Sofieke C.S. de Jonge et al.Osteoarthritis and Cartilage Open, 2024Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the ‘Plants for Joints' randomised clinical trial Carlijn Wagenaar, Wendy Walrabenstein, Marike van der Leeden, et al.RMD Open, 2024A multidisciplinary lifestyle program for metabolic syndrome-associated osteoarthritis: the ‘Plants for Joints' randomized controlled trialAward: Publication of the yearWendy Walrabenstein, Carlijn Wagenaar, Marieke van de Put, et al.Osteoarthritis and Cartilage, 2023A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints' randomized controlled trialWendy Walrabenstein, Carlijn A Wagenaar, Marike van der Leeden, et al.Rheumatology, 2023The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the “Plants for Joints” randomized controlled trial protocolWendy Walrabenstein, Marike van der Leeden, Peter Weijs, et al.Trials, 2021

A recent study published in The Italian Journal of Rheumatology suggests that a gluten free diet could be a promising approach to alleviating fibromyalgia pain and symptoms.Read more about the study here: https://healthnews.com/news/gluten-free-diet-fibromyalgia/?fbclid=IwAR39fWVJvsp9Ud84jGfbj7hDHIJatj3-PQgnCR4E9Zu2hoL7bpJcj5L9430I would love to hear from you! Leave your messages for Andrea at contact@baltimoreglutenfree.com and check out www.baltimoreglutenfree.comInstagramFacebookGluten Free College 101Website: www.glutenfreecollege.comFacebook: http://www.Facebook.com/Glutenfreecollege Hosted on Acast. See acast.com/privacy for more information.

In this powerful and perspective-shifting episode of the UnabridgedMD Podcast, Dr. Isabelle Amigues dives into the groundbreaking Counter Clockwise Study by Harvard psychologist Dr. Ellen Langer, exploring how the way we see ourselves directly shapes our physical health. Dr. Amigues connects this mind-body science to her rheumatology practice — showing that healing isn't only about medication, but also mindset, empowerment, and belief in recovery.Listeners will discover how reprogramming the nervous system, visualizing remission, and embracing a healing identity can truly influence inflammation, disease progression, and overall vitality.✨ Topics Covered:The mind-body connection and its role in inflammation and healingOverview of Dr. Ellen Langer's Counter Clockwise Study and its remarkable resultsHow self-perception and mindset impact disease outcomes in rheumatologyThe role of the parasympathetic nervous system in reducing inflammationPractical ways to “see yourself healthy” and support remissionThe power of group healing and the UnabridgedMD coaching community What if changing how you see yourself could change your health? Start imagining your body in remission — your cells are listening.

They discuss how they became Rheum Champions, their personal journeys with conditions like rheumatoid arthritis, lupus, PCOS, and more, and the importance of community and support. The episode also highlights significant takeaways from the meeting, including research updates, the passion of the researchers, and the heartwarming sense of community.  This podcast serves as a powerful reminder of how important it is to integrate the patient voice into rheumatology research.   *This episode was originally recorded for the My Spoonie Sisters podcast. Episode at a glance:00:00 Welcome to the Rheum Champions Tell All01:59 Introducing the Rheum Champions03:55 Sharing Our Stories: The Journey to Advocacy07:13 The Impact of Community and Support10:55 Becoming a Rheum Champion16:09 Highlights from the 2025 Investigators Meeting24:52 Final Thoughts and How to Get InvolvedMedical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Stay plugged into the conversations, discoveries, and breakthroughs moving rheumatology forward. Real updates. Real context. For clinicians who never stop learning.

In today's episode of the My DPC Story Podcast, host Dr. Maryal Concepcion interviews Dr. Isabel Amigues, the first Direct Specialty Care rheumatologist in Colorado and founder of Unabridged MD in Denver. Dr. Amigues shares her inspiring journey through training in both France and the US, and how surviving stage 4 metastatic breast cancer transformed her medical approach. Blending Western medicine with holistic healing techniques like meditation, visualization, and energy work, she delivers personalized rheumatology care outside the constraints of insurance models. The episode dives deep into her rapid practice growth, patient-centered philosophy, and the advantages of direct specialty care for chronic and autoimmune diseases. Listeners gain valuable insight on patient advocacy, overcoming healthcare burnout, medication access, and building a thriving DPC clinic. Connect with Dr. Amigues for expert rheumatologic care and learn how direct specialty care empowers both physicians and patients. Keywords: direct primary care, direct specialty care, rheumatology, Unabridged MD, Dr. Isabel Amigues, Denver, autoimmune disease, holistic medicine, fee-for-service alternative, physician burnout, patient advocacy.Save $100 on your Hint Summit 2026 ticket through October 31st and join the chorus of direct care leaders shaping tomorrow. Register HERE for the Physician Attendees ONLY RiseUP Summit brought to you by FlexMed Staff & My DPC Story! Get your DPC Resources HERE at mydpcstory.com!Support the showBe A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

In this episode, we sit down with Dr. Kristin to discuss her session at ACR Convergence on taking a personalized approach to pulmonary hypertension in connective tissue diseases. She shares why now is the critical moment for this shift and how “personalized” care extends beyond biomarkers and imaging to encompass clinical nuances, patient-reported symptoms, and multidisciplinary collaboration. We explore the key challenges in detecting pulmonary hypertension early, the promise of emerging technologies like AI-assisted imaging and molecular diagnostics, and the subtle red flags clinicians should recognize in at-risk patients. Dr. Kristin also reflects on her unique dual training in rheumatology and pulmonology, the defining moments that shaped her career, and how mentorship continues to drive innovation and compassion in the care of patients with connective tissue lung disease. 

In this episode, we explore RheumCode, a groundbreaking new initiative from the American College of Rheumatology (ACR) designed to build a common digital language for rheumatology. RheumCode aims to ensure that data means the same thing wherever it lives—whether in an EHR, a clinic, or a registry—enabling systems to seamlessly communicate and make better use of the medical information already being documented. We discussed how RheumCode began, the collaboration behind its development, and its potential to transform the way clinicians practice; researchers study disease, and patients experience their care.  This episode was sponsored by Pfizer  

Dr. Edens debunks common misconceptions, such as vaccines causing autoimmune diseases or always triggering flares. She explains that while mild immune responses are normal, serious complications are extremely rare and the benefits far outweigh the risks. Dr Edens emphasizes that vaccines not only prevent infections but also certain cancers, making them an essential part of care for immunosuppressed patients. The discussion also explores vaccine timing with medications, the dangers of misinformation, and how to talk about vaccine hesitancy with empathy and evidence.Episode at a glance:Guest Expert: Dr. Cuoghi Edens, dual-trained adult and pediatric rheumatologist at the University of Chicago.Myth #1: “Natural is better than vaccines” — Debunked; vaccines dramatically reduce child and adult mortality from infectious diseases.Myth #2: “Vaccines cause autoimmune diseases” — Overwhelming evidence shows they do not.Myth #3: “Vaccines always cause flare-ups” — Possible but uncommon; most patients tolerate vaccines well, and disease prevention outweighs brief discomfort.Risk–Benefit Balance: Vaccines protect against infections and cancers (HPV, hepatitis B) that can worsen or complicate autoimmune diseases.Timing & Medications: ACR guidelines suggest coordination with treatments like rituximab and high-dose steroids, but partial protection is better than none.Health Literacy Tip: “Doing research” means reviewing credible scientific evidence—not social-media opinions or cherry-picked studies.Social Stigma: Addresses misinformation, polarization, and “anti-vax” rhetoric, highlighting the need for compassion and critical thinking.Trusted Resources: Children's Hospital of Philadelphia vaccine education site and American College of Rheumatology guidelines.Key Takeaway: Vaccines are safe, vital, and empowering tools for people with autoimmune diseases.Medical disclaimer: All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! Full Episode Show Notes:Go to the episode page on the Arthritis Life website for full details including a transcript and video!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Welcome to ACR Convergence 2025 in Chicago! Here, Dr. Hausmann delivers a quick update on what our podcasts will cover while the meeting is in session. Don't forget to tune in to ACR on Air and ACR Journals on Air each morning, starting this Saturday, to catch up on the latest in Rheumatology

Description: Listen as NPF Medical Board Members, dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman discuss the connections between psoriasis and psoriatic arthritis, from cytokines to triggers, current and future treatments.   Join moderator Alan Simmons as he gains insights on what connects psoriasis and psoriatic arthritis with leading experts in psoriatic disease and NPF Medical Board members, dermatologist Dr. Robert Kalb with Buffalo Medical Group Dermatology, and rheumatologist Dr. Sergio Schwartzman from Schwartzman Rheumatology, as they discuss the known drivers of psoriasis and psoriatic arthritis, common triggers, benefits of targeted treatments, remission of disease, and upcoming treatment trends. The intent of this episode is to identify potential connections between psoriasis and psoriatic arthritis, and how targeted treatments have changed the outlook for management of psoriatic disease. This episode is sponsored by Novartis. Timestamps: (0:41) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman who are both involved in clinical care and research of psoriasis and psoriatic arthritis.  (1:15) Current known pro-inflammatory cytokines and cells found in psoriasis and psoriatic arthritis.   (5:33) Types of psoriasis that may lead to a higher risk of developing psoriatic arthritis. (9:33) Common triggers for psoriasis and psoriatic arthritis that could cause flares of the disease. (12:59) Key factors that are considered when choosing a treatment plan for any individual with psoriatic arthritis and psoriasis. (18:04) What treatment remission means for psoriasis. (19:36) Use of minimal disease activity (MDA) in psoriatic arthritis and what it means. (22:14) How a better understanding of the disease has led to more effective treatment choices and what choices are used by Dr. Kalb and Dr. Schwartzman for the management of psoriasis and psoriatic arthritis. (28:39) New developments in treatment and research in psoriatic arthritis and psoriasis. (36:01) Given treatment advancements it's a wonderful time to treat psoriatic disease. 3 Key Takeaways: ·       Cytokines are chemicals in the body that moderate various processes. In psoriasis and psoriatic arthritis,  an unknown trigger stimulates some cells to overproduce pro-inflammatory cytokines such as TNF-alpha, IL-17 or IL-23 leading to the development of skin and joint disease.  ·       Treating psoriasis and psoriatic arthritis helps move the body towards normalizing the over reactive immune system especially with more targeted treatments that safely and effectively block specific cytokines without affecting other organ systems.  ·       Given advancements in targeted treatments the goal is to reach and maintain remission of psoriatic disease. Guest Bios:   Leading dermatologist Robert Kalb, M.D. is the Chair of the Buffalo Medical Group Dermatology Department and the Director of the Buffalo Medical Group Phototherapy Center, one of the leading centers for psoriasis care in Western New York. He is also a Clinical Professor of Dermatology at the State University of New York at Buffalo School of Medicine and Biomedical Sciences (SUNY Buffalo), as well as an Adjunct Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania where he plays a significant role in medical education, mentoring both medical students and dermatology residents. Dr. Kalb has extensive experience managing psoriasis, atopic dermatitis, and other inflammatory skin diseases. He has authored 70+ publications and is actively involved in clinical research, particularly focused on new treatment options for psoriasis. He is a member of the NPF Medical Board, American Academy of Dermatology, and is a member of the International Psoriasis Council.  Sergio Schwartzman, MD, is a world-renowned rheumatologist based in New York City who brings almost 40 years of experience and personalized clinical care for those who have psoriatic disease. Along with being in private practice at Schwartzman Rheumatology, Dr. Schwartzman is a Clinical Associate Professor of Medicine at Weill Cornell Medical College of Cornell University, the New York-Presbyterian Hospital, and the Hospital for Special Surgery in New York City where he has played a role in educating medical students, residents, fellows, and peers in rheumatology. Additionally, Dr. Schwartzman is the emeritus Franchellie M. Cadwell Clinical Associate Professor at the Hospital for Special Surgery. Dr. Schwartzman's current research interests include psoriatic arthritis, the spondyloarthritis group of diseases, ankylosing spondylitis, rheumatoid arthritis, as well as defining and treating autoimmune diseases of the eye. He has authored, co-authored, and edited over 150 papers, abstracts, books and book chapters on topics including psoriatic arthritis, ankylosing spondylitis, axial spondylarthritis, rheumatoid arthritis, lupus, autoimmune eye disorders, and other rheumatological and autoimmune conditions. He is a member of the NPF Medical Board. He is also a member of the American College of Rheumatology, the Association for Research in Vision and Ophthalmology, the Spondyloarthritis Research and Treatment Network (SPARTAN), the American Uveitis Society, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Resources: Ø  “Redefining Remission. A new definition for patients, providers, and payers.” Advance Online, National Psoriasis Foundation. S. Schlosser. July 14, 2025.   Ø  Treatment and Management of Psoriasis     Ø  Treatment and Management of Psoriatic Arthritis  

The story of rheumatoid factor could be a 10 minute episode, but in this episode, we dig deep into the history of the lab techniques leading up to this discovery…that happened twice.  ·        Intro 0:04 ·        Rheumatoid factor quick background and history 00:22 ·        Rheumatology blood tests 2:47 ·        What is Rheumatoid factor? 3:39 ·        Spiderman and latex agglutination: Testing for rheumatoid factor 4:49 ·         4:54 ·        The double discovery of rheumatoid factor 7:52 ·        Putting agglutination on the medical map in 1896 10:03 ·        Pop Quiz! 11:04 ·        Serotherapy 13:00 ·        When did we start using agglutination for testing? 14:07 ·        First discovery of blood groups 14:44 ·        The complement fixation test 17:12 ·        Testing for syphilis with complement fixation and agglutination 20:53 ·        The first discovery of rheumatoid factor 24:02 ·        We forget about rheumatoid factor 27:48 ·        Rediscovering rheumatoid factor 28:20 ·        Analytical ultracentrifugation 32:55 ·        What rheumatoid factor is used for 35:50 ·        Thanks for listening 38:09   We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. References: Assadian O et al. Wien Klin Wochenschr. 2010;doi:10.1007/s00508-009-1297-1 Edelman GM, et al. J Exp Med. 1958;doi:10.1084/jem.108.1.105 Franklin EC, et al. J Exp Med. 1957;doi:10.1084/jem.105.5.425 Fraser KJ. Semin Arthritis Rheum. 1988;doi:10.1016/0049-0172(88)90035-2 Jonsson R. Ann Rheum Dis. 2020;doi:10.1136/annrheumdis-2019-216822 Mohd Noor NH, et al. Cureus. 2024;doi:10.7759/cureus.68903 Tan EM, et al. J Exp Med. 2016;doi:10.1084/jem.20160792 Disclosures: Brown reports no relevant financial disclosures.

In this Anxiety Chick's life update episode , Taylor shares the appointment that changed everything: confirmed Hashimoto's thyroiditis and rheumatoid arthritis after years of putting off a positive ANA workup. She opens up about confusing symptoms she'd chalked up to anxiety, why finally seeing a great rheumatologist mattered, and what treatment decisions might look like from here. Alison checks in on her own health journey…follow-up imaging, perimenopause shifts, colonoscopy planning and the very real stress of waiting for results. Together, the Chicks talk about advocating for yourself, finding doctors who listen, using your insurance (PPOs!) strategically, and balancing nervous-system care with medical care. What We Cover Taylor's diagnosis: Hashimoto's + rheumatoid arthritis—what that means and why it's a relief and a lot to process Autoimmune 101: ANA, thyroid antibodies (TPO), flares, allostatic load, and why symptoms can mimic anxiety Next steps: Rheumatology vs. endocrinology, why early treatment can prevent progression, and building a plan When anxiety overlaps with illness: differentiating flares from fear, and why self-gaslighting is easy to do Self-advocacy: symptom logging, asking for an expanded thyroid panel, and the reality that a positive ANA can occur in healthy people Finding the right doctor: why crowdsourced local Facebook groups can beat star ratings, and how to use your PPO without referrals Alison's update: non-invasive imaging follow-up (results pending), perimenopause changes, colonoscopy prep basics, and pacing life when you're overstimulated Nervous system care: stress, sleep, and small tools that help while you wait for answers (including Alison's mention of the Restore Patch) Don't forget to rate and review The Chicks!